| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5928654 | American Heart Journal | 2013 | 14 Pages |
Abstract
The SIGNIFY trial will shed further light on the role of heart rate lowering with ivabradine in patients with stable CAD without clinical heart failure. The study is expected to end in 2014.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kim MD, Ian PhD, Philippe Gabriel MD, Jean-Claude MD, Michal MD, Roberto MD,